Validation Study of a Watch for the Detection of Atrial Fibrillation
- Conditions
- Atrial FibrillationArrythmia, Cardiac
- Registration Number
- NCT04041466
- Lead Sponsor
- Withings
- Brief Summary
The proposed clinical study aims at validating the diagnostic performance, in comparison with a reference ECG, of Withings HWA08 watch for the automatic identification of atrial fibrillation (AF).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 140
- adults, men or women, at least 18 years old
- person having signed the informed consent form
- person affiliated to a social security system
-
vulnerable subject according to current regulation:
- pregnant woman, parturient or breastfeeding
- subject deprived of freedom by judicial, medical or administrative decision
- subject legally protected or unable to express his consent
- subject non-beneficiary of healthcare
- subject falling into more than one of the above categories
-
subject who refused to participate in the study
-
subject in linguistic or psychic incapacity to sign a written informed consent form
-
subject in physical incapacity to wear a watch on their wrist
-
subject with electrical stimulation by pacemaker
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method AF and SR classification accuracy 1 visit (30 minutes) sensitivity and specificity of detection of AF and SR from 1-lead ECG against reference 12-lead ECG
- Secondary Outcome Measures
Name Time Method Quality of the 1-lead ECG strips 1 visit (30 minutes) sensitivity and specificity of detection of AF and SR from 1-lead ECG strips reviewed by a blind, trained cardiologist against reference 12-lead ECG
safety evaluation 1 visit (30 minutes) frequency of adverse events
Trial Locations
- Locations (2)
Clinique AXIUM Centre de cardiologie
🇫🇷Aix-en-Provence, France
Centre Cardiologique du Nord
🇫🇷Saint-Denis, France
Clinique AXIUM Centre de cardiologie🇫🇷Aix-en-Provence, France